Table 3.
Univariate analysis of viral factors for the prediction of chronic obstructive pulmonary disease (COPD) acute exacerbations.
| OR (95% CI) | P-value | |
|---|---|---|
| Detection rate of ADV 2 weeks before AE | 0.9940 (0.9817–1.0064) | 0.1351 |
| Detection rate of IFV 2 weeks before AE | 1.0058 (1.0027–1.0089) | <0.0001 |
| Detection rate of PIV 2 weeks before AE | 0.9968 (0.9847–1.0091) | 0.3923 |
| Detection rate of RSV 2 weeks before AE | 0.9963 (0.9867–1.0060) | 0.3079 |
| Detection rate of hBoV 2 weeks before AE | 0.9864 (0.9641–1.0091) | 0.1299 |
| Detection rate of hCoV 2 weeks before AE | 1.0215 (0.9991–1.0444) | 0.0187 |
| Detection rate of hEV 2 weeks before AE | 0.9895 (0.9579–1.0220) | 0.2925 |
| Detection rate of hRV 2 weeks before AE | 0.9928 (0.9872–0.9983) | 0.0010 |
| Cumulative detection rate of ADV 2–5 weeks before AE | 0.9991 (0.9956–1.0025) | 0.3863 |
| Cumulative detection rate of IFV 2–5 weeks before AE | 1.0015 (1.0007–1.0023) | <0.0001 |
| Cumulative detection rate of PIV 2–5 weeks before AE | 0.9989 (0.9956–1.0023) | 0.2799 |
| Cumulative detection rate of RSV 2–5 weeks before AE | 0.9997 (0.9971–1.0024) | 0.7916 |
| Cumulative detection rate of hBoV 2–5 weeks before AE | 0.9951 (0.9885–1.0017) | 0.0541 |
| Cumulative detection rate of hCoV 2–5 weeks before AE | 1.0072 (1.0009–1.0135) | 0.0050 |
| Cumulative detection rate of hEV 2–5 weeks before AE | 0.9965 (0.9874–1.0057) | 0.2250 |
| Cumulative detection rate of hRV 2–5 weeks before AE | 0.9984 (0.9969–0.9999) | 0.0057 |
OR, odds ratio; ADV, influenza adenovirus; IFV, influenza virus; PIV, parainfluenza virus; RSV, respiratory syncytial virus; hBoV, human bocavirus; hCoV, human coronavirus; hEV, human enterovirus; hRV, human rhinovirus.